國壽資本發起設規模達90億人幣夾層策略基金
中國人壽(02628.HK)(601628.SH)旗下國壽資本投資有限公司日前發起設立規模為90.01億元人民幣的啟航夾層策略型基金。
該基金為市場上首支由境內機構發起設立的聚焦於持有型不動產的夾層策略認繳制股權投資基金,基金將重點投資於服務內循環大局及支持國家戰略新興產業發展的持有型不動產,以踐行保險資金服務實體經濟的社會責任。
同時,基金可有效對衝當前全球低利率環境下的收益率風險,為投資人提供穩定較高的期間收益與退出收益。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.